HOME >> BIOLOGY >> NEWS
U-M scientists target key cells and signals that trigger pulmonary fibrosis

SAN DIEGO Scientists at the University of Michigan Medical School have identified biochemical signals that attract pathogenic cells to damaged lung tissue one of the first steps in a chain of events leading to a lethal disease called idiopathic pulmonary fibrosis or IPF.

Idiopathic pulmonary fibrosis is a progressive disease that kills 40,000 Americans each year. Exposure to toxic environmental agents like beryllium and silica dust can trigger IPF, but in most cases, its cause remains a mystery.

"The disease is devastating to the patients who have it, and to the physicians who have no effective ways to treat it," says Bethany B. Moore, Ph.D., an assistant professor of internal medicine at the U-M Medical School. Working with Galen B. Toews, M.D. a professor of internal medicine and chief of pulmonary and critical care medicine and other Medical School researchers, Moore studies the cells and signaling pathways involved in IPF.

"IPF gradually destroys air sacs in the lung and replaces them with scar tissue making it difficult and eventually impossible for patients to breathe," Moore says. "Most patients aren't diagnosed until the disease is in an advanced stage, and they often die within two years of diagnosis."

By learning more about the basic mechanisms of the disease, U-M scientists hope to uncover new information that could lead to therapeutic drugs to block progressive lung damage or diagnostic tests to make early detection possible.

Moore will present the latest results from her IPF research in a May 23 poster presentation at the American Thoracic Society meeting taking place May 19-24 in San Diego.

Moore studies fibrocytes primitive cells derived from bone marrow that help repair and restore damaged tissue in the body. When lung tissue is injured, damaged cells send out biochemical distress signals that draw fibrocytes from the bloodstream to the injured area. Once in the lung, fibrocytes turn into fibro
'"/>

Contact: Sally Pobojewski
pobo@umich.edu
734-615-6912
University of Michigan Health System
23-May-2006


Page: 1 2 3

Related biology news :

1. UK scientists working to help cut ID theft
2. Smithsonian scientists show differing patterns of rainforest biodiversity
3. Weizmann Institute scientists discover a control mechanism for metastasis
4. Cornell scientists link E. coli bacteria to Crohns disease
5. UCLA scientists produce functioning neurons from human embryonic stem cells
6. ASBMB taps 8 scientists and 1 politician for top awards
7. UF, French scientists seek test to detect gene doping in athletes
8. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
9. Forsyth scientists gain new understanding of adult stem cell regulation
10. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
11. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/14/2018)... ... December 14, 2018 , ... uBiome, the leader in ... for Microbiome-Derived Diagnostics and Therapeutics” by the US Patent and Trademark Office on ... is an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:12/13/2018)... ... 2018 , ... Illumina, Kaiser Permanente, ResMed and Aetna were just a few ... and cooking events company has hosted an impressive guest list of Fortune 500 businesses, ... Each group who visits receives a completely customized experience, right down to the menu ...
(Date:12/10/2018)... , ... December 10, 2018 , ... ... strategic alliance to advance their shared goal of accelerating the development of the ... scale-up bioprocess systems to TRT’s core technology around human umbilical cord perivascular cells ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... January 08, 2019 , ... ... announced today that SAGICO will be represented at the 37th Annual J.P. ... Healthcare Conference is the largest and most informative healthcare investment symposium in ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today ... drug candidate, code-named "KM-819." KM-819 is an orally active small molecule that ... South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
Breaking Biology Technology:
Cached News: